Primo tabs Primobolan 25mg is an oral anabolic steroid. While it has fewer side effects in comparison with other similar drugs, it is a popular choice for those who want to slowly build muscles or for bodybuilders in a dry period of their workout. The dosage of Primobolan Methenolone Acetate generally varies from 75 to 150 mg per day for men and 50 to 75 mg per day for women.
Molecule: Methenolone acetate,
Concentration: 25mg / tabs,
Presentation: 50 tabs,
Recommended dosage: 75-150mg / day
Categories: Alpha Pharma, Primobolan – Methenolone Acetate, Dry Weight Gain, Drying / Weight Loss, Oral Steroids Tags: Alpha-Pharma, Primobolan – Methenolone Acetate
It, also known as Methenolone Acetate, is a popular oral anabolic steroid. It is considered to be a fairly light drug with a small number of side effects in comparison with other similar drugs. Due to its mild character, it is not used to gain exceptional muscle gains in a short period of time, but rather for a slow increase in quality muscles or during a dry period of training, or when There is a need for a light anabolic steroid.
Although they are not common, it is always possible to experience side effects by taking Primobolan Methenolone Acetate. Those that are most prevalent include acne, oily skin, insomnia, anxiety, headaches and hair growth. The most serious side effects of Primo tabs Primobolan 25mg include erectile dysfunction, testicular atrophy and menstrual irregularities in women.
While Primobolan Methenolone Acetate does not aromatize, it is particularly useful for those who are most exposed to estrogen-related side effects like excessive coagulant blood or water retention.
Primo tabs Primobolan 25mg dosages range from 75 to 150 mg per day for men and between 50 and 75 mg per day for women. While Primobolan is often used in different combinations with other steroids to achieve the best results, dosages may vary and depend on combinations with other drugs.
Buy Primo tabs Primobolan 25mg today and start increasing your muscle mass!
There are no reviews yet.